atorvastatin
You searched for “Lipitor”. Shortages and recalls for every US product with this active ingredient.
Shortage
No current shortageFDA shortage list as of Nov 20, 2026
The FDA isn't reporting a shortage for this medicine.
Recalls
9 active, 45 pastFDA recall data as of Nov 11, 2026
- Class IIAtorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Lim
Presence of Foreign Tablets/Capsules
- Class IIAtorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDC 67877-514-05), Manuf
Failed Dissolution Specifications
- Class IIAtorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDC 67877-512-05), c).
Failed Dissolution Specifications
- Class IIAtorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottle (NDC 67877-
Failed Dissolution Specifications
- Class IIAtorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count (NDC 67877-513-05), c
Failed Dissolution Specifications
- Class IIAtorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 088
Failed dissolution specifications: lower than specifications
- Class IIAtorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapo
CGMP Deviations
- Class IIAtorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- Class IIAtorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
A recall usually covers specific lots. Check the lot number on your pack and ask your pharmacist before changing anything.
Information from FDA public data (openFDA), which the FDA says may be unvalidated. Not medical advice.